The SCRS Global Impact Partner (GIP) program offers industry sponsors, CROs, service providers and research sites an opportunity to align with SCRS’ mission of ensuring site sustainability. This unique partnership allows industry leadership to provide input on strategic initiatives for the organization and contribute to SCRS events, committees, publications, advocacy and education for research sites. Through this collaboration, GIPs gain a deeper understanding of the needs of research sites and take part in the development of site-focused solutions within the clinical research marketplace. One representative from each GIP company has a seat on the GIP Board, which interfaces with the SCRS’ Leadership Council to identify advocacy opportunities and programs for the Society.
Learn more about SCRS’ Corporate Sponsorship opportunities.
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.
The PPD clinical research business of Thermo Fisher Scientific enables customers to enhance innovation and drug development productivity. Utilizing patient-centered strategies and data analytics, we cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. thermofisher.com/ppd
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.
Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. www.mdsol.com
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com and follow us on LinkedIn, Twitter, Facebook and Instagram.
Advarra is the premier provider of global research compliance services, including IRB, IBC, consulting, and research technology solutions. Clinical trial sponsors and CROs recognize Advarra as the largest integrated provider of IRB services with the greatest institutional reach among health systems, cancer centers, academic medical centers, and investigators. Forte, now part of Advarra, is the industry’s leading provider of standards-based clinical research technology solutions, incorporating a fully integrated suite for clinical trial management, clinical data management, and research administration, including OnCore CTMS. Advarra accelerates study startup and supports better decision-making by providing robust regulatory expertise and insightful data analytics. Advarra also provides opportunities for continuous learning and collaboration, such as the Onsemble Community and conferences, to support best practices and make research altogether better.
RealTime Software Solution is a global leader in SAAS-based Clinical Trials Management Systems for Sites, Sponsors, and CROs. RealTime is also the only CTMS vendor that can offer a complete suite of solutions into a seamless platform, SOMS (Site Operations Management System). SOMS includes the industry-leading CTMS, SitePAY, TEXT, eDOCS, and eSOURCE which is accessible through an easy-to-use MobileAPP. RealTime also has the most advanced multi-site and site network enterprise systems available anywhere. With an international customer base, multiple integrations with other vendors, advanced recruitment systems, intuitive monitoring portals, Outlook integration, a powerful MobileAPP and more; the team at RealTime has made a significant impact on the efficiency of the clinical research process from start to finish.
The speed, quality, and integrity of endpoint evidence is everything in being able to efficiently advance an experimental therapy forward. Signant is the evidence generation company that helps you digitally enable trials. No matter how or where you run your trials. We make the patient journey more natural and intuitive, and the data journey more direct and objective. With our SmartSignals ecosystem, Signant delivers proof at the speed of life, simplifying and streamlining data generation and reducing the reliance on paper-based evidence gathering and management. We offer vision at a time of change as well as reliability and dependability where it matters most. When the world is counting on you, count on Signant.
4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. For more information, visit www.4gclinical.com.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to improve treatments and advance health solutions for people around the world. www.abbvie.com
Accelerate Recruitment Services provides effective patient recruitment and patient retention solutions for clinical trials through TruView, its proprietary centralized platform. This innovative technology accelerates the enrollment process by connecting patients, sites, and sponsors, promoting diversity in patient populations, and facilitating effective communication. By empowering all stakeholders with real-time data and seamless communication, Accelerate Recruitment Services ultimately enhances trial efficiency and retention.
Advarra is the premier provider of global research compliance services, including IRB, IBC, consulting, and research technology solutions. Clinical trial sponsors and CROs recognize Advarra as the largest integrated provider of IRB services with the greatest institutional reach among health systems, cancer centers, academic medical centers, and investigators. Forte, now part of Advarra, is the industry’s leading provider of standards-based clinical research technology solutions, incorporating a fully integrated suite for clinical trial management, clinical data management, and research administration, including OnCore CTMS. Advarra accelerates study startup and supports better decision-making by providing robust regulatory expertise and insightful data analytics. Advarra also provides opportunities for continuous learning and collaboration, such as the Onsemble Community and conferences, to support best practices and make research altogether better.
AES helps biopharmaceutical companies overcome patient enrollment and research site challenges by combining a powerful patient recruiting solution with more than 150 clinical research sites located throughout the world. As a business of PPD, we are committed to optimizing each step in the patient journey and delivering best-in-class site performance to bring our customers greater certainty to clinical trial delivery. As part of our continued commitment to the environment, and through our partnership with One Tree Planted, we will plant a tree for every patient enrolled in one of our sites.
At AiCure, we put personalized care into the hands of scientists, healthcare professionals and patients through advanced computer vision and machine learning software, empowering unbiased and objective digital diagnoses and predictive insights to optimize care.
Alcanza Clinical Research is the next-generation site network established to support the most significant demands in our industry: diverse patient access, efficient enrollment performance, and clinical quality. We conduct inclusive research to deliver education and a range of clinical trial opportunities to all people on their terms. Located in Alabama, Florida, Massachusetts, Michigan, Missouri, New Hampshire, Puerto Rico, Texas, South Carolina, and Virginia, Alcanza specializes in conditions across psychiatry, neurology, dermatology, and infectious disease therapeutic areas.
The Alliance for Multispecialty Research, LLC is a nationwide company of 17 Clinical Research locations recognized as among the most experienced in the industry. AMR acknowledges the importance of multi-site coordination using our standardized processes. This allows us to maximize economies of scale and consistency in order to exceed Sponsor goals ahead of schedule and under budget.
Headquartered in Fort Worth, Texas, Aspen Insights is a data science and artificial intelligence firm principally engaged in the research, design, development, and integration of healthcare analytics systems, products, and services.
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. www.astrazeneca.com
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In 2016, the Group employed around 115,200 people. For more information, go to www.bayer.com.
As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and is providing the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is also commercializing biosimilars and focusing on advancing the industry’s most diversified pipeline in neuroscience that will transform the standard of care for patients in several areas of high unmet need. The company routinely posts information that may be important to investors on its website at www.biogen.com
Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. www.boehringer-ingelheim.com
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS and, rheumatoid arthritis. At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development. www.bms.com
Centricity Research is a fully centralized Integrated Research Organization (IRO) specializing in conducting Phase I-IV clinical trials in over 35 therapeutic areas: inpatient and outpatient; pharmaceutical, biotechnology, and medical device trials.
Clario delivers the leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives. Through Trial Anywhere™, Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 facilities in nine countries across North America, Europe and Asia Pacific, Clario’s global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years.
Clinical Research Billing is a service for clinical research sites. We work with Clinical Conductor or RealTime to invoice, follow-up and reconcile payments. We take billing off-site, provide financial reports, and support site management, while our expertise in the CTMS makes it easier to use and increases cash flow. Our goal is to provide our financial experience to independent research sites so they can grow profitably and do more research. www.clinicalresearchbilling.com
Cognizant partners with biopharmaceutical and med-tech companies to develop strategies and apply solutions to healthcare challenges across the value chain. Our platforms and services are digitizing interactions between sponsors, investigators, patients, and regulators across every phase, helping the industry subtract time from clinical development and add it to patient lives. To learn more, visit www.cognizant.com.
Clinical Research IO (CRIO) is working to transform the clinical research industry with the latest in cloud and SaaS technology. Built for sites by a former site owner, CRIO offers powerfully integrated eSource, CTMS, eRegulatory and stipend solutions, and protects data integrity with built-in compliance across 21CFR11, ICH-GCP, GDPR, HIPAA and other global regulations. CRIO’s system allows doctors and study coordinators to enter information into an interactive, easy-to-use application. Alerts and automatic calculations make data entry more efficient and accurate – and because everything is available online, site managers can monitor their site’s operations remotely. Join 600+ research sites across the globe who trust and love it!
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
Datacubed Health is a pioneering patient engagement and data collection company making better science and healthier communities a reality. Datacubed applies individualized smartphone solutions for the capture of ePRO and eCOA data, passive data collection, instrument delivery, wearables, and environmental sensors. Focusing on healthcare and life sciences, Datacubed Health offers software and services based on behavioral science to improve patient retention and compliance, resulting in better data and positive health outcomes.
Headquartered in Houston, DM Clinical is a clinical site network with a 15-year track record of excellence. DM Clinical conducts complicated Phase I-IV clinical trials in a broad range of therapeutic areas and specialize in vaccines. DM Clinical represents quality care and results, delivering on enrollment goals, and diverse patient populations.
The Elite Research Network is a group of independently-owned, multi-specialty sites representing capabilities across a wide variety of therapeutic areas and expertise in all clinical trial phases. With expedited start-up timelines and access to diverse patient populations throughout the United States, we’ve been helping our clients achieve their enrollment goals since 2004.
Elixia is a trusted clinical site organization, providing industry-leading patient recruitment and clinical trials management and analysis for Cardiology/Nephrology, Psychiatry/Neurology, Complex Metabolic and Infectious Disease – not just for a single trial, but across your entire therapeutic pipeline.
EMS Healthcare enables the development and delivery of medical solutions deep within the heart of our communities, and we’re committed to creating a future where good health is within everyone’s reach.
EmVenio Research delivers localized trial access to diverse and underserved communities. We empower patients and embrace communities on their terms. Our research solutions cultivate a sustainable local ecosystem that benefits all stakeholders. Removing barriers and unlocking doors to innovation reduces risk and time associated with clinical research while improving ROI. EmVenio Research’s global network of skilled clinicians, principal investigators, and state-of-the-art Community Research sites enables us to provide services via mobile sites, home visits, onsite support at medical facilities, and virtual visits.
Flourish Research is a fully integrated clinical trial company in North America. It acquires and operates large, best-in-class sites with the very best medical and scientific expertise, meaningful diversity, and reliable recruitment.
As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we’re delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier livess beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives.
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. www.gsk.com
Greenphire is the global leader in financial software for clinical trials. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining financial and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. ConneX is the most personalized clinical trial travel solution designed specifically to meet the recruitment and retention goals of domestic and international clinical trials. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. www.greenphire.com.
IMA Clinical Research partners in the development of new medical treatments through a flexible, full-service clinical trial site network. This includes over 20 clinical research sites across multiple therapeutic areas and more than 180 satellite locations, providing diverse patient access across 40 states reaching approximately 50% of the US population. Additionally, our rapidly growing database of 400,000+ patients can reach millions. Finally, we use a modern, tech-enabled operating model to deliver various study designs, including classic site-based, hybrid and fully decentralized trials. Coupled with centralized contracting and rigorous regulatory adherence, we’re uniquely positioned to deliver quick startup and high-quality studies across our network.
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at iqvia.com.
Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care, reaching patients through their trusted physician by integrating research staff and infrastructure. Our broad diverse patient populations ensure clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives through a reimagined approach to clinical trials. For more information, please visit javararesearch.com and follow us on LinkedIn, Twitter, and Facebook.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com
As the drug development business of Laboratory Corporation of America Holdings (Labcorp) and the world’s most comprehensive drug development CRO service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.
M3 Wake Research Integrated Site Network is an owned group of premier clinical research sites that is a unique and innovative resource for Phase I – IV clinical trials. We offer Principal Investigators with a wide variety of therapeutic expertise who conduct studies that are suitable for a demographically and geographically diverse pool of qualified individuals. The Wake Research sites encompass 16 locations in 7 states across the Western, Southern and Southeastern United States with a database reaching nearly one million subjects. We offer partners centralized contract and regulatory support, and feature an in-house marketing and advertising team focused on quick-starts to enrollment. Our board-certified physicians have completed more than 6,000 successful clinical trials. Clinical trials at our sites are completed on time and with accuracy. We consistently exceed sponsor expectations for integrity, subject enrollment, human protection and expeditious delivery of accurate evaluable data.
Medable’s vision is to solve one of the longest-standing challenges in healthcare: biological access to clinical trials. This is realized through a decentralized clinical trial platform that’s proven to shorten trial timelines, create operational efficiencies, and expand trial access to everyone, everywhere. To learn more about us visit www.medable.com
Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. www.mdsol.com
Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious diseases and vaccines, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and orphan disease. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. www.medpace.com
Merck & Co., Inc., Whitehouse Station, NJ, USA is a global healthcare leader working to help the world be well. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook, and YouTube.
Moderna, Inc., based in Cambridge, MA, is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. For more information, visit www.modernatx.com.
As the market leading developer and delivery engine for decentralized clinical trials (DCT), MRN understands the complexities of today’s clinical trial environment and the burdens they place on patients, sites and clients.
Our services are designed to ease these burdens, from community healthcare professionals offering in-home clinical visits through to investigator site professional support, with all the expected support processes, systems and networks, all aimed at accelerating patient recruitment and increasing retention.
We work to maximize the efficiency of clinical trials, by improving the patient’s experience, no matter where their community is in the world.
MRN’s innovative services provide an unparalleled approach to decentralized clinical trials for our clients, expanding the geographical reach and demographic potential of our site partners and allowing more patients greater access to trials.
Since 2006 we have been designing bespoke trial solutions and allying with sites and drug developers to keep the patient at the center of every clinical trial.
Mural Health believes that a clinical trial cannot run successfully if we don’t take special care of the patients and caregivers who make the data collection possible. We’ve made it our mission to make participants’ lives easier and help to bring together diverse lives, from all around the world, so that they can engage with studies and remain engaged from screening until study completion, regardless of their personal circumstances. Using our proprietary mobile application, Mural Link, we are delivering engaging patient payment, transportation, and communication solutions that enable the measurement of participant satisfaction (and drive proactive action to retain participants) across all sites in a study.
Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside of Copenhagen, Denmark. Our purpose is to drive change and defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. For more information visit, www.novonordisk.com, Facebook, Instagram, Twitter.
The story of Pacific Clinical Research Network began with collaboration and a shared vision of healthcare excellence. We are a network of 9 clinical research sites in New Zealand and have been running clinical trials since 2002 across all phases of clinical trials and a wide range of therapeutic areas.
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com and follow us on LinkedIn, Twitter, Facebook and Instagram.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. We collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. www.pfizer.com
Profound Research is an integrated clinical research network composed of trial sites embedded into independent physician practices. Profound’s mission is to expand access to clinical research for patients in the community and give community physicians more therapeutic options. Profound Research has locations across Southern California and in the Detroit metropolitan area and is expanding nationwide. The company has a team of experienced and dedicated research professionals who are committed to providing the highest quality clinical research support to physicians and their patients.
ProofPilot supports clinical trials with the industry’s first fully automated digital protocol platform. The platform orchestrates stakeholder tasks and technology, optimizing clinical workflows, improving stakeholder experiences, and maximizing data quality. Eliminating guesswork and protocol deviations creates high-performance experiences for sites and patients. Founded in 2014, ProofPilot was one of the first global digital clinical trial solutions enabling flawless execution of virtual, hybrid, and in-person research offerings with its patient and site Co-Pilot packages. Learn more at https://www.proofpilot.com
RealTime Software Solution is a global leader in SAAS-based Clinical Trials Management Systems for Sites, Sponsors, and CROs. RealTime is also the only CTMS vendor that can offer a complete suite of solutions into a seamless platform, SOMS (Site Operations Management System). SOMS includes the industry-leading CTMS, SitePAY, TEXT, eDOCS, and eSOURCE which is accessible through an easy-to-use MobileAPP. RealTime also has the most advanced multi-site and site network enterprise systems available anywhere. With an international customer base, multiple integrations with other vendors, advanced recruitment systems, intuitive monitoring portals, Outlook integration, a powerful MobileAPP and more; the team at RealTime has made a significant impact on the efficiency of the clinical research process from start to finish.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases. For additional information about the company, please visit www.regeneron.com
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. For more information, please visit www.roche.com.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). www.sanofi.us
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. Through our Metasite™ we reach an expanded population beyond the traditional site, delivering on our goal of clinical research that works for everyone—with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own homes, at their local community provider, or at a traditional site when needed. Our Metasite is powered by a proprietary technology platform with in-house medical and operational experts that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email science37@science37.com.
Scout empowers clinical trial sites worldwide, offering tailored assistance through Scout Meetings, Scout Clinical, and Scout Academy. Since 1995, we have eased the burden on sites by specializing in patient payment processes, travel logistics, and virtual collaboration. Our expertise spans 109 countries, ensuring compliance with international regulations and providing exceptional customer support. Scout provides clinical trial sites with customizable, comprehensive services and white-glove attention to detail, streamlining operations and enhancing efficiency. Explore our people-first solutions at scoutclinical.com.
The speed, quality, and integrity of endpoint evidence is everything in being able to efficiently advance an experimental therapy forward. Signant is the evidence generation company that helps you digitally enable trials. No matter how or where you run your trials. We make the patient journey more natural and intuitive, and the data journey more direct and objective. With our SmartSignals ecosystem, Signant delivers proof at the speed of life, simplifying and streamlining data generation and reducing the reliance on paper-based evidence gathering and management. We offer vision at a time of change as well as reliability and dependability where it matters most. When the world is counting on you, count on Signant.
Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions that include eConsent, IRT and eCOA, delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,500 trials across 85 countries. To learn more, visit suvoda.com. Follow Suvoda on LinkedIn.
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 240 years of distinguished history in Japan.
TD2 provides innovative services for improved and accelerated development of medicines for cancer. Our team has deep experience and understanding in drug development. Preclinical development, combined with regulatory affairs expertise, guides customized clinical trial design and execution. Our capabilities encourage the timely selection of patient populations who are most likely to benefit from a new agent, and the rapid identification of clinically significant endpoints.
The PPD clinical research business of Thermo Fisher Scientific enables customers to enhance innovation and drug development productivity. Utilizing patient-centered strategies and data analytics, we cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. thermofisher.com/ppd
TPS is a clinical research solutions company focused on deploying strategic resources empowered by technology; designed to address critical development needs across the industry. Our SiteChoice™ solution provides Sponsors with the ability to invest in the infrastructure of their clinical research sites, improving study conduct and quality while enhancing the patient recruitment and experience.
Velocity Clinical Research is wholly owned and dedicated solely to clinical research networks that connects researchers, doctors, and patients with the shared goal of bettering research across the industry – all in one place. We are a true “one stop shop” for high quality research and results. Each of our research facilities focuses solely on conducting clinical trials and collecting the most accurate data possible. Research should never be an afterthought. At Velocity, it’s the priority.
YPrime solutions simplify clinical trial management. We build our technology on the latest platforms, holding ourselves to the highest quality measures. From designers and developers to managers and support techs, our seasoned team works with one goal in mind: Ensuring an optimal experience for sponsors, sites and patients.
ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 37 years of experience and 10,000-plus ZSers in 28 offices worldwide, we’re passionately committed to helping companies and their customers thrive. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.